Form D · Biotechnology
GUARDIAN BIOMEDICAL CORP.
Tampa, FL · CIK 0002113154
Offering snapshot reported Mar 3, 2026 · SEC filing
- Reported sold
- $60K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 21, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2026 | Initial | $60,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-575228
SAFEs
Source: Form D, filed Mar 3, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Manny Manzel | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4920 W. Cypress St. 104 #5076
Tampa, FL, 33607
Phone: 631-697-6941
Tampa, FL, 33607
Phone: 631-697-6941